- Report
- January 2019
- 348 Pages
Global
From €4004EUR$4,400USD£3,433GBP
- Report
- July 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,131GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1320EUR$1,450USD£1,131GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
The Cannabis Testing market is a subset of the Drug Abuse Screening market, which is focused on the detection of illicit drugs in biological samples. Cannabis Testing is used to detect the presence of cannabinoids, such as THC and CBD, in biological samples. This type of testing is used to identify individuals who are using cannabis for recreational or medical purposes, as well as to detect individuals who are using cannabis illegally. Cannabis Testing is also used to monitor the potency of cannabis products, as well as to detect the presence of contaminants, such as pesticides and heavy metals.
Cannabis Testing is typically performed using a variety of analytical techniques, such as gas chromatography, mass spectrometry, and immunoassays. These techniques are used to detect the presence of cannabinoids, as well as to measure the concentration of cannabinoids in a sample.
Some companies in the Cannabis Testing market include Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, PerkinElmer, and Waters Corporation. Show Less Read more